Solventum Co. (NYSE:SOLV) Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio decreased its holdings in shares of Solventum Co. (NYSE:SOLV) by 16.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 74,425 shares of the company’s stock after selling 14,356 shares during the period. Public Employees Retirement System of Ohio’s holdings in Solventum were worth $5,189,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of SOLV. Worldquant Millennium Advisors LLC grew its position in Solventum by 373.6% during the third quarter. Worldquant Millennium Advisors LLC now owns 47,665 shares of the company’s stock worth $3,323,000 after buying an additional 37,600 shares during the period. The Manufacturers Life Insurance Company grew its holdings in shares of Solventum by 37.4% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 117,853 shares of the company’s stock worth $8,217,000 after acquiring an additional 32,051 shares during the period. State Street Corp increased its stake in Solventum by 3.1% in the 3rd quarter. State Street Corp now owns 6,107,550 shares of the company’s stock valued at $425,818,000 after purchasing an additional 185,938 shares in the last quarter. Point72 Asset Management L.P. acquired a new position in Solventum during the third quarter worth $50,948,000. Finally, First Horizon Advisors Inc. purchased a new stake in Solventum during the second quarter worth $58,000.

Wall Street Analysts Forecast Growth

SOLV has been the subject of a number of research analyst reports. Stifel Nicolaus assumed coverage on Solventum in a research report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price target for the company. Mizuho started coverage on shares of Solventum in a report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price for the company. Wolfe Research initiated coverage on shares of Solventum in a report on Thursday, September 26th. They issued a “peer perform” rating on the stock. BTIG Research initiated coverage on shares of Solventum in a research report on Thursday, September 5th. They issued a “neutral” rating on the stock. Finally, Piper Sandler lifted their price objective on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $68.29.

Solventum Stock Performance

Shares of NYSE SOLV opened at $69.56 on Friday. The firm’s 50 day moving average price is $70.91 and its 200 day moving average price is $63.22. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $96.05.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.